The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
June 1st 2023
Each month, our editorial staff compiles a recap of the top news in endocrinology from the past month. Our May 2023 month in review features new FDA approvals, important phase 2 data, and in-depth clinician perspective.
Increased Physical Activity Could Slow Progression to Type 1 Diabetes in Autoantibody-Positive ChildrenMay 11th 2023
An analysis of data from the TEDDY study suggests increased levels of moderate to vigorous physical activity could reduce risk of progression to type 1 diabetes in multiple islet autoantibody-positive children.
Depression or Anxiety During Pregnancy Could Increase Type 1 Diabetes Risk for OffspringMay 4th 2023
An analysis of more than 1.8 million mother-offspring pairs offers new insight into a potential association between exposure to maternal depression/anxiety during pregnancy and risk of type 1 diabetes in offspring during adolescence.
Endocrinology Month in Review: April 2023May 2nd 2023
Each month, our editorial staff compiles a recap of the top news in endocrinology from the past month. Our April 2023 month in review features top new studies, FDA approvals, and an overview of news surrounding Abbott readers.
Endocrine Case Report: Thumb Swelling and RednessMay 1st 2023
Our latest case report from Brady Pregerson, MD, featuresa woman in her mid-60s with a history of Hashimoto’s thyroiditis treated with levothyroxine presenting to the hospital with 4-5 days of pain, swelling and redness on her left thumb.
Thyroid Cancer in Type 2 Diabetes Linked to Elevated Triacylglycerol, Total Cholesterol Levels
The serum glycated hemoglobin levels and the incidence of thyroid cancer in patients with type 2 diabetes in patients with type 2 diabetes were significantly higher in the observation group when compared with the control group.
FDA Approves Medtronic's MiniMed 780G System for People with Type 1 DiabetesApril 22nd 2023
On April 21, 2023, Medtronic announced the long-awaited US approval of their MiniMed 780G System with Smart Guard Technology and the Guardian 4 Sensor, which has been available in Europe for nearly 3 years.
Obstructive Sleep Apnea Amplifies Cardiovascular Risk in Women with ComorbiditiesApril 21st 2023
In patients hospitalized with acute coronary syndrome and metabolic syndrome, obstructive sleep apnea was associated with an increased risk of major adverse cardiovascular and cerebrovascular events in women, but not in men.
Endocrine Case Report: Ear Pain in DiabetesMarch 27th 2023
Our latest endocrine case report from Brady Pregerson, MD, features a patient in their mid-70s with a history of diabetes mellitus and end-stage kidney disease presenting with 6 days of gradually worsening right ear pain. Can you determine the correct diagnosis?
Rising Gestational Diabetes Rates Could Be Result of Changes in Screening PracticesMarch 20th 2023
An analysis of more than 500,000 pregnancies over a 15-year period suggests much of the increase in gestational diabetes rates observed during the study period can be attributed to changes in screening practices.
Endocrine Case Report: Insomnia After Transient Ischemic AttackMarch 13th 2023
This endocrine case report features a patient in their mid-50s with a history of recent TIA presenting to the hospital with increasing anxiety and insomnia over the past week. Can you determine the correct diagnosis?
New Therapies to Delay T1D ProgressionFebruary 8th 2023
Robin S. Goland, MD, and Kimberly Simmons, MD, MPH/MSPH, provide insight on teplizumab, which was recently approved by the FDA, to delay the progression of type 1 diabetes, and they discuss the implications of autoantibody detection in patients.
Shared Decision-Making to Improve Long-Term Outcomes in Diabetes and ObesityFebruary 8th 2023
Drs Diana Isaacs and Natalie Bellini highlight the need for engaging patients in shared decision-making and addressing social determinants of health in diabetes and obesity management in adults and pediatric patients.
Controversial Use of New Diabetes and Obesity Medications and Steps to Initiate Discussion About Weight ManagementFebruary 8th 2023
Scott Kahan, MD, MPH, discusses with Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, and Natalie Bellini, DNP, FNP-BC, how the controversial use of new diabetes and obesity medications is creating access issues for people who really need these medications, and shares strategies to initiate the conversation about weight management with patients.
Weight Management Updates in the 2023 ADA Standards of CareFebruary 8th 2023
Dr Scott Kahan shares the latest updates to the 2023 ADA Standards of Care related to weight management and describes the different weight loss approaches recommended by the ADA.
Challenges with Current Staging Systems for ObesityFebruary 8th 2023
Scott Kahan, MD, MPH, discusses the shortcomings of the current staging systems used for overweight and obesity and recommends the use of weight-related health and functional status in addition to BMI.